Arrevus Competitors and Similar CompaniesClear all
Arrevus's competitors and similar companies include BIoEclipse Therapeutics, VCN Biosciences and NKGen Biotech.
 BIoEclipse Therapeutics BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics. |  VCN Biosciences VCN Biosciences is a company focused on the development of therapeutic approaches for tumor treatment. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. | ||
Founding Date | Founding Date 2017 | Founding Date N/A | Founding Date 2009 | Founding Date 2017 |
Type | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations HQ | Locations South San Francisco, US HQ Mountain View, US | Locations Sant Cugat del Vallès, ES HQ | Locations Santa Ana, US HQ |
Employees | Employees 3 | Employees 614% decrease | Employees 9 | Employees 7316% increase |
Funding | ||||
Total funding raised | Total funding raised $ 1m | Total funding raised $ 7.7m | Total funding raised N/A | Total funding raised $ 11m |
For sources of this data, please see the company profile
View Company Profiles
BIoEclipse Therapeutics
HQ
South San Francisco, US
Employees
6↓ 14% decrease
BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics.
View companyVCN Biosciences
HQ
Sant Cugat del Vallès, ES
Employees
9
VCN Biosciences is a company focused on the development of therapeutic approaches for tumor treatment.
View companyNKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View company